SNY News

Latest SNY News

• Sanofi Updates Share Capital and Voting Rights Structure
  TipRanks European Auto-Generated Newsdesk · Oct 12, 2026
• Barclays Reaffirms Their Sell Rating on Polestar Automotive Holding UK (PSNY)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
• Tesla Rival Polestar Stock (PSNY) Pops as Q3 Sales Rise Despite Looming U.S. Market Ban
  Solomon Oladipupo · Oct 8, 2026
• J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
• Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Option Care Health (OPCH)
  TipRanks Newsroom · Oct 6, 2026
• Sanofi Terminates Amlitelimab Asthma Extension Study: What Investors Should Watch
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
• Real-World Dupixent Data in Itchy Skin Disease: What Sanofi and Regeneron Investors Should Watch
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 1, 2026
• Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Sagimet Biosciences, Inc. Class A (SGMT) and Eli Lilly & Co (LLY)
  TipRanks Newsroom · Oct 1, 2026
• Sanofi (SNYNF) Gets a Buy from Jefferies
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 1, 2026
• Sanofi and Regeneron Deepen $8 Billion Immunology Alliance for Next-Gen Antibodies
  TipRanks European Auto-Generated Newsdesk · Oct 1, 2026
• Sanofi’s Teplizumab Study Signals a New Front in Pediatric Type 1 Diabetes
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 29, 2026
• Sanofi (SNYNF) Receives a Buy from Deutsche Bank
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 29, 2026
• Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 22, 2026
• Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 18, 2026
• Itepekimab COPD Extension Trial Completion: What It Means for Regeneron and Sanofi
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 18, 2026
• Sanofi Strikes Strategic Deal With Cheplapharm to Hand Over 20 Mature Medicines and Three Plants
  TipRanks Auto-Generated Newsdesk · Sep 17, 2026
• Synergy CHC Faces Nasdaq Delisting Amid Chapter 11
  TipRanks Auto-Generated Newsdesk · Sep 16, 2026
• Sanofi Targets Senior Respiratory Risk With New Phase 2b RSV+HMPV Vaccine Trial
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 16, 2026
• RBC Capital Keeps Their Hold Rating on Sanofi (SNYNF)
  TipRanks Auto-Generated Intelligence Newsdesk · Sep 15, 2026